Wells Fargo
SPRB icon

Wells Fargo’s Spruce Biosciences SPRB Stock Holding History

Wells Fargo’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126K Buy
+2,329
New +$130K ﹤0.01% 5439
2024
Q2 		– Sell
-2
Closed -$112 – 7590
2024
Q1 		$112 Hold
2
– – ﹤0.01% 6628
2023
Q4 		$413 Hold
2
– – ﹤0.01% 6430
2023
Q3 		$294 Hold
2
– – ﹤0.01% 6486
2023
Q2 		$400 Buy
2
+1
+100% +$167 ﹤0.01% 6536
2023
Q1 		$148 Sell
1
-5
-83% -$929 ﹤0.01% 6846
2022
Q4 		$511 Sell
6
-3
-33% -$251 ﹤0.01% 6378
2022
Q3 		$1K Sell
9
-5
-36% -$699 ﹤0.01% 6498
2022
Q2 		$2K Sell
14
-51
-78% -$6.53K ﹤0.01% 6395
2022
Q1 		$10K Sell
65
-61
-48% -$11.4K ﹤0.01% 6276
2021
Q4 		$43K Sell
126
-20
-14% -$5.95K ﹤0.01% 6041
2021
Q3 		$66K Buy
146
+52
+55% +$32.6K ﹤0.01% 5532
2021
Q2 		$79K Buy
94
+65
+224% +$69.4K ﹤0.01% 5388
2021
Q1 		$36K Sell
29
-21
-42% -$32.2K ﹤0.01% 5967
2020
Q4 		$90K Buy
+50
New +$82.9K ﹤0.01% 5403

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Ikarian Capital
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ADAR1 Capital Management
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Cable Car Capital
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

Wells Fargo's SPRB Position: Q2 2026 in Review

Wells Fargo opened a new position in Spruce Biosciences (SPRB) in Q2 2026: 2,329 shares worth $126K. The stake represents ﹤0.01% of the portfolio and ranks #5439 among its holdings. This is a return to the name: Wells Fargo previously reported a position in SPRB as recently as Q1 2024.

Wells Fargo first reported a position in SPRB in Q4 2020 and has held it in 15 quarters since. 64 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Wells Fargo held 2,329 shares of Spruce Biosciences worth $126K as of Q2 2026.
  • Spruce Biosciences was a new Wells Fargo position in Q2 2026.
  • Spruce Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5439 holding.
  • Wells Fargo first reported a position in Spruce Biosciences in Q4 2020 and has held it in 15 quarters since.
  • 64 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.